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ISSCR: President’s NoteReflections of an ISSCR President, 2010–2011As I reach the end of my presidency of the ISSCR, I’ve come to
realize that what makes this society special is its cohesiveness,
openness, and sense of community. The leadership of the ISSCR
is dynamic, ever-changing with each coming year. Past leaders
work together with present and future leaders to form a
continuum of momentum that fuels existing initiatives and
launches new ones. The ISSCR’s staff, headed by Executive
Director Nancy Witty, has been tireless in their devotion to
meeting the objectives of the society. During this past year, top
stem cell researchers throughout the world have participated
with staff in telephone conference calls—held at wee hours of
the morning for some and late hours into the night for others—
to provide me with information and counsel regarding urgent
policy matters, annual and regional meetings, educational initia-
tives, new ISSCR awards, and strategies for raising the neces-
sary finances that will allow ISSCR to broaden its initiatives
and support the education and training of the world’s future
stem cell researchers and translational physician scientists.
Awards are one way we can acknowledge the contributions to
the field made by our members. This past year, we continued to
recognize the key contributions of the new generation of scien-
tists committed to stem cell biology with the award of the third
annual Outstanding Young Investigator Award to Robert Blelloch
(profiled in this issue of Cell Stem Cell; Kriegstein, 2011). In addi-
tion, we were delighted to add two new awards to our portfolio,
the McEwen Centre Award for Innovation and the ISSCR Public
Service Award. The McEwen Centre Award for Innovation, sup-
ported by the McEwen Centre for Regenerative Medicine in
Toronto, Ontario Canada, recognizes original thinking and
groundbreaking research pertaining to stem cells or regenerative
medicine that opens new avenues of exploration toward the
understanding or treatment of human disease or affliction. We
are pleased to present this award for the first time at the
2011 Annual Meeting to Drs. Kazutoshi Takahashi and Shinya
Yamanaka, for their paradigm-shifting work demonstrating the
reprogramming of somatic cells using transcription factors, a
technology that has rapidly been adopted and developed by
the research community to address a myriad of biological and
medical questions. We will also present the inaugural ISSCR
Public Service Award to Robert Klein, Chairman of theGoverning
Board of the California Institute for Regenerative Medicine
(CIRM), for his outstanding contribution of public service to the
field of stem cell research and regenerative medicine. Through
his vision and leadership, Bob Klein secured for California
long-term financial support for stem cell research that has
provided a framework to foster new and established talent, inno-
vative science, and clinical application. Bob’s advocacy for
stable financial support for stem cell research on the interna-
tional stage is unprecedented.
As we face the next decade, stem cell researchers stand at
a nexus with physicians, biotechnology, and the pharmaceutical
industry in advancing the most promising medical treatments of
our generation. But this promise can only become a reality if we
are able to broaden and bolster our efforts to educate students,
the public, sciencewriters, and policymakers so that they under-stand the vital importance of this research and the need to
pursue and support it.
As the voice of ethically and scientifically sound stem cell
research and its application worldwide, the ISSCR must
strengthen our message and also work hard to unearth new
avenues to expand research support in the face of economically
hard times. The ISSCR needs the entire stem cell community to
join us in our efforts to achieve these goals and keep the future of
stem cell research and regenerative medicine bright. The great-
est danger we face is complacency with our great science and
translational research at a time when support—financial and
practical—for stem cell research is being challenged worldwide.
Widespread misperceptions and misinformation about stem
cells are fueling this danger. We owe it to the public, the patients,
and future generations to assume our responsibility and take on
a more proactive role in education at all levels.
One of the greatest misperceptions in the public ethos is that
stem cell therapy is something still on the horizon. In fact, it dates
back to the 1950s and 60s, when kidney, bonemarrow, liver, and
heart transplants marked a new way of treating devastating
human disorders for which there had previously been no hope
for survival. These early medical treatments, now in practice
throughout the world, represented the dawn of stem cell thera-
pies and regenerative medicine. Close to my heart, in the
1970s, Howard Green developed methods for culturing human
epidermal stem cells in the laboratory under conditions where
their activity was maintained long term. His team soon applied
this methodology to treat burn patients, now a 30 year success
story. The success of Michele De Luca and colleagues, in adapt-
ing this methodology to culture corneal stem cells for the treat-
ment of blindness, has now been followed for 10 years. With
the groundbreaking work in converting human skin fibroblasts
into induced pluripotent stem cells (iPSCs), and with continued
work on their embryonic counterparts, the door is now open
wider than ever before for deepening our understanding of
many devastating diseases for which there is currently no cure.
Every month, scientists are reporting successes in generating
disease-specific iPSCs or directing their differentiation to
uncover new and valuable insights into the phenotypes of devas-
tating human diseases. Moreover, when coupled with improve-
ments in iPSC generation, researchers are moving toward the
creation of patient-specific iPSCs that could be differentiated
into desired cell types for possible clinical applications. As the
history of biomedical science has demonstrated time and time
again, basic research andmechanistic understanding are critical
steps in improving diagnostics and developing treatments for
disease.
The existing examples of stem cell therapies in the clinic show
that translation of basic discoveries into medical treatments
takes time. However, they also underscore that stem cell thera-
pies do not simply hold promise—there are already longstanding
successes of these therapies, with others on the horizon. The
promise that stem cell research holds for the next decade is
for the development of many new and improved therapies over
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many of which were not even thought possible just a few years
back. Moreover, the benefits of stem cell research are not limited
to stem cell therapies themselves. Pharmaceutical and biotech-
nology industries are clamoring for the knowledge and tech-
nology stem cells offer to improve diagnostics and design of
new small molecules, drugs, and multidrug treatments for
a variety of human disorders.
Many of the arguments in opposition of certain avenues of
stem cell research are not based on scientific understanding.
Many science writers need greater knowledge about the major
progress in stem cell therapies over the past 50 years and of
the enormous potential—and also pitfalls—that stem cell re-
search holds. Many governments may not recognize the devas-
tating impact that cutting back or restricting basic stem cell
research could have on the health and economic growth of their
nations. The public often doesn’t realize that basic science is the
necessary foundation for the development of clinical applica-
tions. Even well-intentioned leaders who hold the purse strings
of the limited government dollars for research, who come under
governmental or public pressures to forego basic science,
should be reminded that support for basic science is what
always has and always will serve as the driving force behind clin-
ical and translational applications, as well as new and improved
drugs for the treatments of human disease. The answer is clearly
outreach and education, and we are all, in my view, called to
share the responsibility to engage society in our science,
whether it is the public, government, media, our peers, or our
families. Our own research and that of the generations that we
have trained and will train is dependent upon our stepping up
to the plate to convey our knowledge to others. In turn, we
owe it to theworld to conduct our research in an ethically respon-
sible fashion and to meet patient standards for safety and effec-
tiveness of stem cell therapies.
I hope these points will encourage you to talk with friends,
colleagues, and the public and to engage your local govern-
mental representatives and science writers, perhaps inviting630 Cell Stem Cell 8, 629–630, June 3, 2011 ª2011 ISSCRthem to visit your laboratories, meet your teams, and learn about
the passion that we have for what we do and why we do it. I also
hope that you will open your laboratory doors to a high school
student, undergraduate, or teacher to conduct research for
a summer and help bridge the gap between scientists and
schools. Being married to the Director of Philosophy and Educa-
tion at Teacher’s College at Columbia University, I may be biased
in my view that the answer is always rooted in education. That
said, I do strongly believe that after all these years, we still
have something to learn from Plato’s dialogs about the things
that matter in human life, and from recognizing that science
cannot operate in a vacuum. We need the world’s help, and it
is our responsibility to convey our excitement and enthusiasm
for what we do and its enormous benefit to mankind to those
who either never knew or have forgotten.
The ISSCR 2010 Annual Report, ‘‘‘Connecting a World of
Possibilities,’’ published in Cell Stem Cell in April, delineated
a number of new educational initiatives that the ISSCR will be
developing over the coming year. These efforts will continue
when Fred Gage becomes our next ISSCR president at the
conclusion of this year’s June ISSCR meeting. Some, such as
our collation of stem cell resources and tools for undergraduate
teaching, are already underway. Look for additional opportuni-
ties to support this and future efforts over the upcoming year.
And finally, if you haven’t done so already, please become
amember of the ISSCR.With your help, our society can continue
to improve and expand our educational initiatives with the ulti-
mate goal of advancing stem cell research and translation for
the future. I look forward to seeing you all at the 9th Annual ISSCR
Meeting, June 15th –18th, 2011 in Toronto, and I am grateful to all
of you for giving me the opportunity to serve you as your presi-
dent over this past year.REFERENCE
Kriegstein, A. (2011). Cell Stem Cell 8, this issue, 631–632.Elaine Fuchs
President, ISSCR (2010–2011), Rockefeller University, Howard
Hughes Medical Institute
DOI 10.1016/j.stem.2011.05.003
